AMRI (AMRI) Misses Q4 EPS by 1c; Guides Q111, FY11 Revs Below Street
Tweet Send to a Friend
Albany Molecular Research Inc. (NASDAQ: AMRI) reported Q4 loss of $0.16, 1 cent ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
